Pancreatic Cancer Research

ResearcherTongji UniversityActive in the last 2 years

Dachuan Qi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1089-0014; OpenAlex author ID A5056596151. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper

Papers 3

  1. CUL2 confers ferroptosis resistance in pancreatic cancer by disrupting KEAP1-mediated NRF2 degradation. Last author DOI 10.1186/s12935-025-04005-4↗
  2. RRP9 promotes gemcitabine resistance in pancreatic cancer via activating AKT signaling pathway. Co-author DOI 10.1186/s12964-022-00974-5↗
  3. T cell immunoglobulin- and mucin-domain-containing molecule 3 gene polymorphisms and susceptibility to pancreatic cancer. Last author DOI 10.1007/s11033-012-1862-y↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Kui Yu · 1 shared paper, 2025 · strength 0.25
  2. Lijuan Yang · 1 shared paper, 2025 · strength 0.25
  3. Zhi‐Qi Zhang · 1 shared paper, 2022 · strength 0.14
  4. Danian Tong · 1 shared paper, 2012 · strength 0.03
  5. Zhenyi Jia · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.